| __timestamp | Bausch Health Companies Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 31354781 |
| Thursday, January 1, 2015 | 582800000 | 43445817 |
| Friday, January 1, 2016 | 455000000 | 66489820 |
| Sunday, January 1, 2017 | 366000000 | 96886134 |
| Monday, January 1, 2018 | 414000000 | 153793000 |
| Tuesday, January 1, 2019 | 471000000 | 148369000 |
| Wednesday, January 1, 2020 | 452000000 | 151934000 |
| Friday, January 1, 2021 | 465000000 | 198532000 |
| Saturday, January 1, 2022 | 529000000 | 112128000 |
| Sunday, January 1, 2023 | 604000000 | 76192000 |
Unlocking the unknown
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, TG Therapeutics, Inc. and Bausch Health Companies Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Bausch Health consistently allocated a significant portion of its budget to R&D, peaking in 2023 with a 145% increase from 2014. This commitment underscores their focus on expanding their product pipeline and enhancing existing treatments. In contrast, TG Therapeutics, Inc. exhibited a more volatile R&D expenditure pattern, with a notable surge in 2021, marking a 533% increase from 2014. This spike reflects their aggressive pursuit of breakthrough therapies.
These trends highlight the dynamic nature of R&D investments in the biopharma sector, where strategic financial decisions can shape the future of healthcare innovation.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
R&D Spending Showdown: Incyte Corporation vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Bausch Health Companies Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.